Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
Comprehensive financing for Honeywell spinoff of Honeywell Aerospace
We advised the banks on the debut investment-grade senior notes offering, cash tender offer and revolving credit facilities
Valero Energy $850 million senior notes offering
We advised the joint book-running managers on the offering
Baker Hughes $6.5 billion senior notes offering
We advised the underwriters on the investment-grade notes offering
Baker Hughes €3 billion senior notes offering
We advised the underwriters on the investment-grade notes offering
Abbott Laboratories $20 billion notes offering
We advised the joint book-running managers on the offering
indie Semiconductor $150 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
Canadian Pacific Railway $1.2 billion notes offering
We advised the joint-bookrunning managers on the investment grade offering
Niagara Mohawk Power $1 billion senior notes offering
We advised the underwriters on the offering
AbbVie $8 billion senior notes offering
We advised the representatives of the underwriters on the offering